Drug class in one race
JAK1 drugs for Atopic Dermatitis
7 tracked JAK1 drugs in the Atopic Dermatitis race. The class explanation lives on the JAK1 page; the full indication pipeline across every mechanism is on the Atopic Dermatitis page.
2 approved / phase 43 Phase 32 Phase 2
Head-to-head evidence: IN-115314 vs LNK01001 · IN-115314 vs LW402 · abrocitinib vs IN-115314 · IN-115314 vs upadacitinib · JYP0061 vs LNK01001 · JYP0061 vs LW402